NervGen Pharma Corp (NGEN)

[timberwolf7]

Have tracked NGEN(f) for a few years now. In their investor
deck is several 'testimonials' from clinical trial participants.
An end of PH 2 meeting with the fda 1st half of 2026.
Been telling myself, IF this showed effectiveness? Minimal
side effects by the end of the PH 2?

What would the odds be for something with the potential to seriously
impact folks lives in a very good way, not needing a full PH 3, maybe
even not needing a PH 3 to get approved. And running a PH 3 as a
confirmation data gathering effort post approval instead of denying this
potential treatment for another likely 1 1/2 to 2 years to do a PH 3??

disclaimer: don't own any. Concern over a couple of aspects:
Market cap already sitting at $430 Mil based on around 80 Mil
shares. $11 Mil or so in cash on hand (will they need more dilution?)
Chance for a buyout??

To close, like what I am seeing, but what is the fda giong to say in response
to the results. Cause having to develop and run a PH 3... Good luck..